Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action.

Vollenweider FX, Vollenweider-Scherpenhuyzen MF, Bäbler A, Vogel H, Hell D

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (0)

No references identified in the available metadata. This does not establish that none exist.

    Cited by — these papers cite this paper (49)

    1. Enhancing cGMP signaling with psilocybin reduces head twitch and restructures the synaptic proteome while maintaining antidepressant response 2026-10-12 · Expand citations
    2. Exploring the In Vitro Effect of Psilocybin on the Composition and Metabolic Activity of Gut Microbiota in Individuals with Severe Anxiety 2026-08-12 · Expand citations
    3. Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants 2026-07-01 · Expand citations
    4. Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headache 2026-05-29 · Expand citations
    5. Human brain changes after first psilocybin use 2026-05-05 · Expand citations
    6. Psilocin mediates long-term synaptic depression in the prelimbic cortex through 5-HT2A receptor-independent mechanisms 2026-05-01 · Expand citations
    7. Psilocybin ameliorates neuropathic pain-like behaviour in mice and facilitates gabapentin-mediated analgesia 2026-04-24 · Expand citations
    8. Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons 2026-03-27 · Expand citations
    9. Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy 2026-03-01 · Expand citations
    10. Distinguishing 4- vs 5-Hydroxy- N, N -Dimethyltryptamine (Psilocin vs Bufotenine) Using Hydrogen-Deuterium Back-Exchange 2026-02-04 · Expand citations
    11. Towards "unmakable" psychedelics: SAR exploration of psilocin analogs obtained by a HATU-mediated amide coupling strategy 2025-12-01 · Expand citations
    12. A Comparative Neurophenomenology of the Psychedelic State and Autism: Predictive Processing as a Unifying Lens 2025-11-14 · Expand citations
    13. Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidence 2025-10-27 · Expand citations
    14. Cross-Species Evidence for Psilocin-Induced Visual Distortions: Apparent Motion Is Perceived by Both Humans and Rats 2025-09-01 · Expand citations
    15. The Medial Prefrontal Cortex Modulates Psychedelic-like Effects of Psilocin 2025-08-08 · Expand citations
    16. The psychedelic renaissance: psilocybin, a breakthrough for treatment resistant depression? 2025-08-07 · Expand citations
    17. Psilocybin-gestützte Therapie von Depression, Angst und Suchtstörungen: Neurobiologische Grundlagen und klinische Anwendung 2025-05-01 · Expand citations
    18. Psychedelics for Moral Bioenhancement in Healthy Individuals-A Violation of the Non-Maleficence Principle? 2025-02-06 · Expand citations
    19. The many faces of psilocybin-related psychosis: A case series 2024-12-07 · Expand citations
    20. Psychedelic trip sitting, dosages and intensities: Supplementing clinical studies with anecdotal reports 2024-07-17 · Expand citations
    21. Psilocybin in the Management of Substance Use Disorders: A Summary ofCurrent Evidence 2024-07-04 · Expand citations
    22. In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin 2024-04-29 · Expand citations
    23. Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder 2024-03-07 · Expand citations
    24. Pharmacology and Therapeutic Effects of Psilocybin 2023-08-29 · Expand citations
    25. Underlying pharmacological mechanisms of psilocin-induced broadband desynchronization and disconnection of EEG in rats 2023-06-22 · Expand citations
    26. Conformational Landscape and Hydrogen Bonding Pattern of Psilocin: Computational Insights 2023-01-09 · Expand citations
    27. Psilocybe mexicana R. Heim - Mexikanischer Kahlkopf 2022-04-01 · Expand citations
    28. Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory mice 2022-02-23 · Expand citations
    29. Unravelling a New Conformer of Psilocin Through Computational Methods 2022-01-01 · Expand citations
    30. Safer Tripping: Serotonergic Psychedelics and Drug Checking. Submission and Detection Rates, Potential Harms, and Challenges for Drug Analysis 2021-07-26 · Expand citations
    31. Effectiveness of Psilocybin on Depression: A Qualitative Study 2021-04-27 · Expand citations
    32. Development and validation of an LC-MS/MS method for the bioanalysis of psilocybin’s main metabolites, psilocin and 4-hydroxyindole-3-acetic acid, in human plasma 2021-02-01 · Expand citations
    33. Plasma psilocin critically determines behavioral and neurobiological effects of psilocybin 2021-01-01 · Expand citations
    34. A potential role for psilocybin in the treatment of obsessive-compulsive disorder 2020-06-01 · Expand citations
    35. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels 2019-06-01 · Expand citations
    36. The Experience Elicited by Hallucinogens Presents the Highest Similarity to Dreaming within a Large Database of Psychoactive Substance Reports 2018-01-21 · Expand citations
    37. Tripping up addiction: the use of psychedelic drugs in the treatment of problematic drug and alcohol use 2016-11-14 · Expand citations
    38. Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain 2015-12-01 · Expand citations
    39. Effect of Psilocin on Extracellular Dopamine and Serotonin Levels in the Mesoaccumbens and Mesocortical Pathway in Awake Rats 2015-01-01 · Expand citations
    40. The Effect of Psilocin on Memory Acquisition, Retrieval, and Consolidation in the Rat 2014-05-16 · Expand citations
    41. Fungal Hallucinogens Psilocin, Ibotenic Acid, and Muscimol 2013-08-01 · Expand citations
    42. Enzyme-assisted synthesis of the glucuronide conjugate of psilocin, an hallucinogenic component of magic mushrooms 2011-09-01 · Expand citations
    43. Acute toxicity of Psilocybe cubensis (Ear.) Sing., Strophariaceae, aqueous extract in mice 2010-07-01 · Expand citations
    44. Psilocybin slows binocular rivalry switching through serotonin modulation 2010-03-19 · Expand citations
    45. Other Times I Can Barely See: The Effects of Hallucinogens on Vision and Attention 2009-12-31 · Expand citations
    46. Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines 2008-10-30 · Expand citations
    47. Involvement of 5-HT2A Receptor in the Regulation of Hippocampal-Dependent Learning and Neurogenesis 2007-12-31 · Expand citations
    48. Concise Large-Scale Synthesis of Psilocin and Psilocybin, Principal Hallucinogenic Constituents of “Magic Mushroom” 2003-06-01 · Expand citations
    49. Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in man 2002-09-01 · Expand citations